← Leaderboards
Paul Vanheldhuisen
The Emmes Company, Llc
$5,463,397
Attributed
$5,463,397
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.3M · FY2012–14$5M$3.8M$2.5M$1.3M$0
'12
'13
'14
Funding mix
By agency
NIH$5,463,397 · 1
By mechanism
N01$5,463,397 · 1
Top collaborators
No co-investigators on record.
Most similar at The Emmes Company, Llc
Same institution · by research overlap
- Paul Vanveldhuisen$63,018,753
- Robert Lindblad$59,748,609
- Eve Jelstrom$42,013,348
- Donald Stablein$6,357,875
- Greg Doyle-Wandell$13,880,931
Others in their field
Top investigators on “Alcohol Or Other Drugs Use”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$397,601,754
- Constance Ann Benson · University Of California, San Diego$204,627,497
- Sharon A Nachman · Johns Hopkins University$197,601,947
- Carol Nesel · Westat$188,148,170
Research focus
Alcohol Or Other Drugs UseAreaBaseClinicClinical ResearchClinical TrialsCommon Data ElementData CollectionData ManagementDesignDrug AbuseFlexibilityInformation SystemsLeadershipMeetingsNational Institute Of Drug AbuseOnline SystemsProtocols DocumentationQuality ControlReportingResearch DesignResearch SupportScienceServices
Grant awards (3)
OTHER FUNCTIONS: DATA, STATISTICS, AND CLINICAL TRIAL SUPPORT FOR NIDA. N01DA-12$971,980
N01 · FY2014 · DA · contact PI
OTHER FUNCTIONS: DATA, STATISTICS, AND CLINICAL TRIAL SUPPORT FOR NIDA. N01DA-12$1,179,284
N01 · FY2013 · DA · contact PI
OTHER FUNCTIONS: DATA, STATISTICS, AND CLINICAL TRIAL SUPPORT FOR NIDA. N01DA-12$3,312,133
N01 · FY2012 · DA · contact PI